Anaphylactic shock in a beta-blocked child: usefulness of isoproterenol

Mona Momeni1, Barbara Brui, Philippe Baele

  • 1Department of Anesthesiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. mona.momeni@clin.ucl.ac.be

Paediatric Anaesthesia
|August 9, 2007
PubMed

Insights

Children on beta-blockers face serious risks during anaphylaxis. A case study shows isoproterenol effectively treated severe bradycardia in a beta-blocked child experiencing anaphylactic shock resistant to standard treatments.

Area of Science:

  • Pediatric Cardiology
  • Anaphylaxis Management
  • Pharmacology

Background:

  • Beta-blocker medications are commonly prescribed for pediatric cardiovascular conditions.
  • Anaphylaxis, a severe allergic reaction, can cause life-threatening hemodynamic instability.
  • Children on beta-blockers may have an altered response to anaphylaxis triggers.

Observation:

  • A pediatric patient on beta-blockers experienced anaphylactic shock following aprotinin administration.
  • The patient developed severe bradycardia (slow heart rate).
  • Standard treatments, including intravenous epinephrine and fluid resuscitation, were ineffective.

Findings:

  • The anaphylactic shock and severe bradycardia were resistant to conventional therapies.
  • Isoproterenol, a beta-adrenergic agonist, was administered.
  • Isoproterenol successfully resolved the bradycardia and stabilized the patient's hemodynamics.

Implications:

  • This case highlights the potential for severe hemodynamic compromise in beta-blocked children during anaphylaxis.
  • It underscores the limitations of standard anaphylaxis treatments in this population.
  • Isoproterenol may be a crucial alternative treatment for managing refractory bradycardia in pediatric anaphylaxis when beta-blockers are involved.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Allergic Reactions02:06

Allergic Reactions

Overview
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...